Successful cutaneous sensory blockade following single and double injection techniques of ultrasound-guided superficial parasternal intercostal plane (PIP) block: A randomized controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230408004

Enrollment

140

Registered

2023-04-08

Start date

2023-04-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Successful cutaneous sensory blockade following single and double injection techniques of ultrasound-guided superficial parasternal intercostal plane (PIP) block in patients undergoing open cardiac surgery ultrasound-guided superficial parasternal intercostal plane block, cardiac surgery, median sternotomy, CABG, valvular heart surgery, analgesia

Interventions

injection of local analgesic into the pecto-intercostal plane at the 3rd ICS 3 cm lateral to the mid sternum,injection of local analgesic into the pecto-intercostal plane at the 2nd and 4th ICS 3 cm l

Active Comparator Drug,Active Comparator Drug

single injection technique of ultrasound-guided superficial parasternal intercostal plane (PIP) block,double injection technique of ultrasound-guided superficial parasternal intercostal plane (PIP) bl

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients between 20 - 70 years old 2. American Society of Anesthesia (ASA) physical status II - IV 3. Undergoing elective coronary artery bypass graft surgery (CABG) or valvular surgery with median sternotomy 4. Body weight > 50 kg

Exclusion criteria

Exclusion criteria: 1. Patients who refused to participate in this trial 2. Patients who allergic to bupivacaine and dexamethasone, renal or hepatic failure, coagulopathy, chronic pain, and drug addiction. 3. Morbid obesity (BMI > 40 kg/m2) 4. Secondary median sternotomy or emergency cardiac surgery 5. Inability to communicate such as language barrier and deafness

Design outcomes

Primary

Measure	Time frame
successful cutaneous blockade of T2-T6 dermatomes over the medial chest wall after single and double injection techniques at 30 minutes after nerve block numbness and loss of sensation of T2-T6 dermatomes over the medial chest wall	—

Secondary

Measure	Time frame
analgesics consumption, pain score, safety and recovery profile postoperative period postoperative periodat 6th, 12th, 24th, 36th, 48th and 60th hour the amount of opioid consumption ( mcg), numeric rating scale, the time to extubation in postoperative period	—

Countries

Thailand

Contacts

Public ContactArtid Samerchua

Chiang Mai university

artidsamerchua@gmail.com053935522

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026